Real-world pharmacovigilance assessment of meropenem-associated adverse events: age stratification and time-to-onset analysis using FAERS
Xiaobin Luo, Yali Zhong, Yong Zou, Chenghao Yang · 2026
Read Real-world pharmacovigilance assessment of meropenem-associated adverse events: age stratification and time-to-onset analysis using FAERS by Xiaobin Luo, Yali Zhong, Yong Zou, Chenghao Yang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13506888.txt.
Description
BackgroundMeropenem is a broad-spectrum carbapenem antibiotic widely used for severe infections; however, its real-world adverse event profile and age-stratified pharmacovigilance signals remain insufficiently characterized. This study aimed to evaluate signals of meropenem-associated adverse events using the FDA Adverse Event Reporting System (FAERS).MethodsFAERS reports from 2004 Q1 to 2025 Q4 were extracted.
Catalog record
| CREATOR | Xiaobin Luo, Yali Zhong, Yong Zou, Chenghao Yang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 84 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |